BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Sunesis Pharmaceuticals Appoints Industry Veteran H. Ward Wolff to the Board of Directors

  Mr. Wolff most recently having served as Executive Vice President and Chief Financial Officer of Sangamo Therapeutics.

  February 8, 2018

   · 

  5 min read
• Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus

  The Preliminary Shelf Prospectus and corresponding shelf registration statement have not yet become final or effective.

  February 8, 2018

   · 

  5 min read
• Business

  Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46%

  Total revenue was $4.8 million for the third quarter as compared to $3.4 million for the same period last year.

  February 8, 2018

   · 

  15 min read
• Biotech Bay

  Personalis Launches ImmunogenomicsID for Multidimensional Immuno-Oncology Biomarker Analysis

  Personalis today announced the launch of ImmunogenomicsID, a new component of the ACE ImmunoID Platform.

  February 8, 2018

   · 

  2 min read
• Business

  Aytu BioScience Provides Fiscal Second Quarter 2018 Business Update - Live Conference Call and Webcast Today at 4:30 pm ET

  Aytu BioScience today provided an overview of its business, including the Company’s operational and financial results for its fiscal second quarter ended December 31, 2017.

  February 8, 2018

   · 

  20 min read
• Business

  Mettler-Toledo International Reports Fourth Quarter 2017 Results

  Sales in local currency increased 6% in the quarter compared with the prior year.

  February 8, 2018

   · 

  41 min read
• FDA

  QIAGEN’s QuantiFERON-TB Gold Plus Gains Approval in Japan

  QIAGEN N.V. today announced that Japan’s Ministry of Health Labor and Welfare has approved QuantiFERON-TB Gold Plus (QFT-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection.

  February 8, 2018

   · 

  1 min read
• Business

  Innoviva Reports Record Fourth Quarter and Full Year 2017 Financial Results

  Income from operations for the fourth quarter of 2017 was $66.4 million, compared with $37.7 million for the same period in 2016.

  February 8, 2018

   · 

  16 min read
• Biotech Bay

  Adverum Biotechnologies Announces Pricing of $60M Public Offering of Common Stock

  Adverum Biotechnologies today announced the pricing of an underwritten public offering of 8,888,900 shares of its common stock at a price to the public of $6.75 per share.

  February 8, 2018

   · 

  3 min read
• Business

  Nevro to Report Operating Results for the Fourth Quarter and Full Year 2017

  Following the call, a replay will be available on the Investor Events and Presentations webpage of the Company’s website.

  February 8, 2018

   · 

  1 min read